[Relation of C-reactive protein and coronary heart disease. Current knowledges].
Originally meant as a marker of inflammation in coronary heart disease (CHD), C reactive protein (CRP) is becoming an important tool in the clinical management of CHD patients. Several studies, and in particular the recent JUPITER trial, confirm its feasibility in intermediate risk patients; furthermore, according to last evidence, CRP could be a target for new therapeutic strategies.
Biasillo
Gina
G
Istituto di Cardiologia, Dipartimento di Medicina Cardiovascolare, Policlinico Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma.
De Maria
Giovanni Luigi
GL
Leo
Milena
M
Stefanelli
Antonella
A
Biasucci
Luigi Marzio
LM
D002097:C-Reactive Protein / Q000037:antagonists & inhibitors / Q000502:physiology*; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D011379:Prognosis; D018570:Risk Assessment
D002097:C-Reactive Protein